July 2025 Life Sciences Mega Close: Frazier Life Sciences Closes $1.3B Fund XII
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
Venture capital fuels the companies that reshape industries — from AI infrastructure and fintech to healthcare and defense tech. This hub collects our latest analysis on how VC firms evaluate startups, structure deals, and deploy capital across stages and geographies.
Browse the articles below to research investors, understand deal dynamics, and build a sharper fundraising strategy.
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
Greenwich and Miami-based Glade Brook Capital closed Strategic Growth Fund IV at $515 million on July 22, 2025, targeting FinTech, AI, SpaceTech, and DefenseTech growth equity.
New York City-based Betaworks announced the $66M close of Fund III on July 22, 2025, continuing its legacy of backing creative technologists building AI-native products.
Houston-based Modi Ventures closed its oversubscribed second fund at $88 million on July 16, 2025, investing at the intersection of AI, biology, and medical technology.
Former Coatue partner Kris Fredrickson closed Verified Capital Fund I at $175M in July 2025 — a concentrated 8–10 bet strategy backed by Harvey AI, Coinbase, and Instacart founders.
New York-based Quartus Capital Partners closed its Quartus AI Fund LP at $50M+ on July 14, 2025, deploying into growth-stage AI ventures across healthcare, education, and logistics.